AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
BIC Announces No Trading in Own Shares for July 2025
ByAinvest
Friday, Aug 1, 2025 11:46 am ET1min read
BIC, a global stationery and lighters company, disclosed no transactions in its own shares for July 2025. The company's next financial updates include Q3 2025 net sales on October 28, 2025, and full-year 2025 results on February 24, 2026. BIC has a presence in over 160 countries and a portfolio of iconic brands and products.
United Therapeutics Corporation (NASDAQ: UTHR) stock experienced a 4% increase on Friday morning following the announcement of a $1 billion accelerated share repurchase (ASR) program. The company entered into two ASR agreements with Citibank, N.A., totaling $1 billion, with an initial upfront payment of $1 billion on August 4, 2025. The agreements include a $500 million collared and a $500 million uncollared agreement. United Therapeutics will receive approximately 75% of shares under the uncollared agreement and about 50% under the collared agreement [1].The repurchase program reflects the company's confidence in its stock's intrinsic value and its ability to generate sustained revenue and cash flow growth. Final settlement for the uncollared ASR is expected in the fourth quarter of 2025, while the collared ASR should settle in the first quarter of 2026. The final number of shares repurchased will be based on the average daily volume-weighted average price during the term of the agreements. United Therapeutics had approximately 45.2 million shares outstanding as of July 30, 2025 [1].
Meanwhile, the broader market has remained relatively flat over the past week, with no significant sector-specific movements. However, over the past year, the market has experienced a 4.8% growth, and earnings are expected to grow by 7.7% per annum over the next few years [2].
In related news, BIC, a global stationery and lighters company, disclosed no transactions in its own shares for July 2025. The company's next financial updates include Q3 2025 net sales on October 28, 2025, and full-year 2025 results on February 24, 2026. BIC has a presence in over 160 countries and a portfolio of iconic brands and products [3].
References:
[1] https://www.investing.com/news/stock-market-news/united-therapeutics-stock-jumps-on-1-billion-share-repurchase-plan-93CH-4165687
[2] https://simplywall.st/stock/tse/3048
[3] https://www.globenewswire.com/news-release/2025/07/30/3124284/0/en/BIC-First-Half-2025-Results.html
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet